Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ansgar Wilhelm Lohse"'
Autor:
Silja Steinmann, Johannes Hartl, Sören Weidemann, Katja Füssel, Claudia Kroll, Marcial Sebode, Ansgar Wilhelm Lohse, Christoph Schramm
Publikováno v:
JHEP Reports, Vol 5, Iss 12, Pp 100898- (2023)
Background & Aims: Concurrent fatty liver disease represents an emerging challenge in the care of individuals with autoimmune liver diseases (AILD). Therefore, we aimed to validate the ultrasound-based method of controlled-attenuation parameter (CAP)
Externí odkaz:
https://doaj.org/article/416818fc3bf04958a6c1329d434a9c34
Autor:
Alena Laschtowitz, Kalliopi Zachou, Vasiliki Lygoura, Simon Pape, Finn Derben, Elmar Jaeckel, Sergio Oller-Moreno, Sören Weidemann, Till Krech, Felix Piecha, Gerhard Schön, Anna-Maria Liebhoff, Munira Al Tarrah, Michael Heneghan, Joost P.H. Drenth, George Dalekos, Richard Taubert, Ansgar Wilhelm Lohse, Christoph Schramm
Publikováno v:
JHEP Reports, Vol 3, Iss 4, Pp 100321- (2021)
Background & Aims: In autoimmune hepatitis (AIH), normal levels of transaminases and IgG define biochemical remission and are considered the best surrogate markers for histological remission. This study assessed whether this also applies to patients
Externí odkaz:
https://doaj.org/article/4cfa3834a47c4ab2bd5a92770f31ddb1
Autor:
Johannes Hartl, Rosa Miquel, Kalliopi Zachou, Guan-Wee Wong, Asma Asghar, Simon Pape, Marcial Sebode, Moritz Peiseler, Roman Zenouzi, Hanno Ehlken, Till Krech, Christina Weiler-Normann, Joost P.H. Drenth, Ye H. Oo, George Nikolaos Dalekos, Michael Heneghan, Christoph Schramm, Ansgar Wilhelm Lohse
Publikováno v:
JHEP Reports, Vol 2, Iss 3, Pp - (2020)
Background & Aims: High IgG levels are considered a hallmark of autoimmune hepatitis (AIH). A subgroup of patients with AIH has IgG within the normal range despite evidence of clinical disease activity. The clinical significance of this biomarker has
Externí odkaz:
https://doaj.org/article/bcca109810554658a87eabfcfdf0b496
Autor:
Ewa Wunsch, Linda Krause, Tom JG Gevers, Christoph Schramm, Maciej K. Janik, Marcin Krawczyk, José Willemse, Natalie Uhlenbusch, Bernd Löwe, Ansgar Wilhelm Lohse, Piotr Milkiewicz
Publikováno v:
Liver International, 43, 381-392. Wiley
BACKGROUND AND AIMS: Autoimmune liver diseases (AILDs) are associated with impaired health-related quality of life (HrQoL). The aim of this project was to identify potentially modifiable factors related to HrQoL in a large transnational cohort of pat
Publikováno v:
Journal of Hepatology. 78:893-895
Autor:
Johannes Hartl, Darius Ferenc Rüther, Paul Maria Duengelhoef, Thomas Theo Brehm, Silja Steinmann, Jan Philipp Weltzsch, Fabian Glaser, Martina Sterneck, Marcial Sebode, Christina Weiler‐Normann, Marc Lütgehetmann, Golda Melina Schaub, Friedrich Haag, Christoph Schramm, Julian Schulze zur Wiesch, Ansgar Wilhelm Lohse
Publikováno v:
Liver international : official journal of the International Association for the Study of the LiverREFERENCES.
To explore the humoral and T-cell response to the third COVID-19 vaccination in autoimmune hepatitis (AIH).Anti-SARS-CoV-2 antibody titers were prospectively determined in 81 AIH patients and 53 healthy age- and sex-matched controls7 days (median 35)
Autor:
Darius Ferenc Rüther, Jan Philipp Weltzsch, Christoph Schramm, Marcial Sebode, Ansgar Wilhelm Lohse
Publikováno v:
Journal of hepatology. 77(1)
Autor:
Fayez Awwad, Ann-Kathrin Ozga, Tania Amin, Catarina Schlueter, Sajeda Kailani, Daniel Perez, Stefan Wolter, Guido Sauter, Jakob Izbicki, Ansgar Wilhelm Lohse, Joerg Schrader
Publikováno v:
Neuroendocrinology. 112(12)
Introduction: Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group of neoplasms. Surgery is the only curative treatment option. However, our understanding of predictors of survival after surgery remains incomplete. The aim of the study
Publikováno v:
Hepatology. 21:190-198
Publikováno v:
Hepatology. 21:190-198
Concanavalin A activates T lymphocytes in vitro and causes T-cell-dependent hepatic injury in mice. T lymphocytes were previously identified as effector cells of concanavalin A-induced liver injury. Here we report that hepatic injury is characterized